DESCRIPTION:
The course “Clinical trials and AI: design faster and start smarter with Clincraft” offers an updated overview of the evolution of clinical trials, highlighting the need for innovation in an increasingly digital context. ClinCraft, the new software developed by IDM Insight to support the start-up phase of clinical studies with a focus on protocol design, will be presented. A live demo of the software in action will then be shown, along with selected case studies.
WHY ATTEND THIS TRAINING:
This course is essential for anyone who wants to understand how technology is transforming the world of clinical research, improving its efficiency and reliability.
By the end of the course, participants will have gained practical tools and knowledge to integrate digital innovation into their clinical projects using ClinCraft, while complying with scientific and ethical-regulatory requirements.

WHIT ALESSIO DE SIMONE
Alessio De Simone is an expert in drug discovery and clinical development, with a strong academic background in Pharmaceutical Chemistry and Technology (University of Pisa) and a PhD in Drug Discovery and Development obtained between the Italian Institute of Technology and the University of Oxford. After post-doctoral research experience in Edinburgh and a role as Senior Scientist at Sygnature Discovery (UK), he held managerial positions in the international clinical field. He is currently Chief Medical Officer at IDM Insight and works as a freelance consultant. His focus includes computational and medicinal chemistry, clinical studies, and the use of artificial intelligence in drug development.t.
COURSE CURRICULUM
- QeA2_What strategies does IDM Insight offer to help companies start working with this type of approach? (4:51)
- QeA1_how are update manage in the platform? (0:52)
- QeA3_Does it also cover medical device trials and drugs? (2:38)
- QeA4_To what extent will CRAs be involved in overseeing AI-generated results, and how might this affect their jobs? (3:06)
- QeA5_Can the tool adapt the final report to the specific type of call? (1:23)